Naama Epstein-Rigby
10PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 02, 2025
The Feasibility and Applicability of Pediatric Inpatient Beta Lactam De-Labeling: From Bedside Challenge to Long-Term Follow Up.Michal Paret, Rinat Komargodski, Bella London
|Nov 20, 2025
Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk-Treatment Protocol.Na'ama Epstein-Rigbi, Matan Elkan, Yair Tzarfati
|May 03, 2024
Beta-lactam antibiotics administration among adult inpatients with a beta-lactam allergy label: incidence, predictors, and outcomes.Naama Epstein-Rigbi, Sharon Ziv, Marina Bulanenkova
|Aug 22, 2023
Sesame eliciting and safe doses in a large sesame allergic population.Liat Nachshon, Joost Westerhout, W Marty Blom
|Oct 03, 2022
Efficacy and safety of food allergy oral immunotherapy in adults.Na'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon
|Jan 09, 2022
Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study).Arnon Elizur, Michael Y Appel, Liat Nachshon
Pageof 2
Frequent Collaborators
8 joint publications
Liat Nachshon
6 joint publications
Michael R Goldberg
5 joint publications
Arnon Elizur
1 joint publications
Matan Elkan
1 joint publications
Michal Paret
1 joint publications
Rinat Komargodski
1 joint publications
Bella London
1 joint publications
Hadas Paz
1 joint publications
Michael Y Appel
1 joint publications
Jonas Lidholm
